comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 18:07:15 - browse：1

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Why Charlie Gard's case is so disturbing to Americans

WSS

Sana to lay off nearly a third of staff, de

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Histogen: Failed biotech offers rare public look inside

Bill would stop addiction treatment from triggering child abuse inquiry

Analysis of telehealth claims data suggest service duplication

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Wikipedia

comprehensive

explore

Medical records are filled with copy

Retired US general questions alleged Putin, Prigozhin meeting

Bright Health sells Medicare Advantage business to Molina

Why Charlie Gard's case is so disturbing to Americans

Medical leaders decry Supreme Court decision on affirmative action

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Hollywood unions extend contract negotiations for actors

Bulgari apologizes to China for listing Taiwan as a country after online backlash

In Memoriam: Notable people who died in 2023

How the political right came to back psychedelics to treat trauma

focus

Beach reads and more: STAT's 2023 summer book list

Study: Pain burden is higher in Black NFL players than white ones

Was Amgen transparent enough on FDA's concern on cancer drug?

What to expect at HLTH 2023, the health care industry conference

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Petition to FDA: Get the lead out of consumer hair dyes

focus

leisure time

hotspot

entertainment